|
- Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø¿¡¼´Â 2006³âºÎÅÍ Çѱ¹º¸°Ç»ê¾÷ÀÇ ¹ßÀü°ú ±â¼ú»ç¾÷ÈÀÇ ÀåÀ¸·Î½á ±¹³» ÃÖ´ë BIO Çà»çÀÎ BIO KOREA¸¦ °³ÃÖÇØ¿À°í ÀÖ½À´Ï´Ù.
- ¸Å³â 4500¿©¸íÀÌ Âü¼®ÇÏ´Â ÄÁÆÛ·±½º´Â °¢ ºÐ¾ß Àü¹®°¡µéÀÌ Âü¿©ÇÏ¿© ÃֽŠÀü¹®Áö½Ä°ú ±â¼ú Åä·ÐÀÇ ÀåÀ¸·Î ÀÚ¸®¸Å±èÇØ ¿Ô½À´Ï´Ù. 2012³âµµ ÄÁÆÛ·±½ºÀÇ ¼º°øÀûÀÎ °³ÃÖ¸¦ À§ÇØ BIO ºÐ¾ßÀÇ ¼¼°èÀûÀÎ ¼®ÇÐ, ±¹³»¿Ü ¹ÙÀÌ¿À ±â¾÷ÀÇ CEO, ¹ÙÀÌ¿À»ê¾÷ Á¾»çÀÚ, ¿¬±¸±â°ü, Çмú´ÜüÀÇ ´ëÇÐ ±³¼ö´Ô ¹× Àü¹®°¡ ºÐµéÀÇ Âü¿© µ¶·Á¸¦ À§ÇÑ Volunteer Speaker¸¦ ¸ðÁýÇϰí ÀÖ½À´Ï´Ù.
¡ØVolunteer Speaker : Volunteer Speaker¿¡°Ô´Â BIO KOREA¿¡¼ ¿¬»ç·á¸¦ ´ë½ÅÇÑ °¨»çÆÐ¿Í BIO KOREA Àüü Çà»ç ¹«·á Âü°¡ ƼÄÏ(Full Convention Access)À» Á¦°øÇص帳´Ï´Ù.
o BIO KOREA 2012 °ø¸ð ÁÖÁ¦
|
BIO KOREA 2012 Conference |
|
Tissue Engineering & Stem Cell |
BIO M&A |
GMPegulatory Process |
|
Vaccine |
Clinical Drug Development |
Food & Agriculture - GMO |
|
Regenerative Medicine |
Personalized Medicine |
Regulatory Approval |
|
BIO Energy |
Therapeutic Antibodies |
Cancer |
|
Life Science Business Models |
Biologic |
Drug Repositioning Strategy |
|
Intellectual Property |
Translational Research |
Capitalinance |
|
Medical Service |
Bio-drug Delivery System |
Bio-similar |
|
Technology Transfer & Licensing |
Biomarkers |
Health Bioinformatics |
|
Bioprocess Manufacturing |
Nanotechnology |
Natural Products |
|
Molecular Diagnostics |
u-health |
Global Innovation & Market |
¡Ø »ó±â ÁÖÁ¦ ¿Ü Ãß°¡ ÁÖÁ¦ ¹× º¹¼ö °ø¸ðµµ °¡´ÉÇÕ´Ï´Ù.
o °ø¸ð ±âÇÑ ¹× Á¦Ãâ ¹æ¹ý
- 2011³â 12¿ù 26ÀÏ(¿ù)
- Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø ±â¼ú»ç¾÷ȼ¾ÅÍ BIO KOREA 2012 ÄÁÆÛ·±½º ´ã´çÀÚ ¾Õ À̸ÞÀÏ biokoreaconference@gmail.com Á¢¼ö / T. 043-713-8852
- Á¦Ãâ ¾ç½Ä [ºÙÀÓ] ÷ºÎ
|